Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease based » disease based (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease based » disease based (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
-
41
-
42
-
43
Data for subjects with significant slopes (regional progression or recovery colour coded, non-significant regions white) for the 4 data types over the study period.
Published 2023“…<p>The only diabetic (non-DMO) person with significant thickness changes was mf87171 (row I). …”
-
44
-
45
-
46
-
47
-
48
-
49
Summary of the earliest time point for significant WD-induced changes in NASH-associated markers.
Published 2023“…The figure illustrates the earliest time point for a significant change in the marker abundance and whether the marker <b>Increased</b> or <b>Decreased</b> in response to the WD. …”
-
50
-
51
Evaluation of changes in some cytokine levels in survivor and non-survivor groups.
Published 2021Subjects: -
52
Change in the levels of parental stressors or rewards between time point 1 and time point 2.
Published 2022Subjects: -
53
-
54
-
55
-
56
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
57
-
58
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
59
-
60